Search

Your search keyword '"Brooks, Oliver"' showing total 163 results
Start Over Author "Brooks, Oliver"
163 results on '"Brooks, Oliver"'

2. Use of COVID-19 Vaccines for Persons Aged [greater than or equal to] 6 Months: Recommendations of the Advisory Committee on Immunization Practices-United States, 2024-2025

Author

Panagiotakopoulos, Lakshmi, Moulia, Danielle L., Godfrey, Monica, Link-Gelles, Ruth, Roper, Lauren, Havers, Fiona P., Taylor, Christopher A., Stokley, Shannon, Talbot, H. Keipp, Schechter, Robert, Brooks, Oliver, Daley, Matthew F., Fleming-Dutra, Katherine E., and Wallace, Megan

Subjects
Vaccination -- Usage, Drug approval -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Pfizer Inc., United States. Food and Drug Administration
Abstract

On Tuesday, September 10, 2024, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Introduction COVID-19 continues to account for thousands of hospitalizations and hundreds [...]

Published
2024

6. Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged [greater than or equal to]65 Years: Recommendations of the Advisory Committee on Immunization Practices--United States, 2024

Author

Panagiotakopoulos, Lakshmi, Godfrey, Monica, Moulia, Danielle L., Link-Gelles, Ruth, Taylor, Christopher A., Chatham-Stephens, Kevin, Brooks, Oliver, Daley, Matthew F., Fleming-Dutra, Katherine E., and Wallace, Megan

Subjects
United States. Department of Health and Human Services, Pfizer Inc., Epidemics -- United States, Vaccination -- Usage -- Health aspects, Public health -- Health aspects -- Usage, Adults -- Health aspects -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Health aspects -- Usage, Health
Abstract

Introduction Since June 2020, CDC's Advisory Committee on Immunization Practices (ACIP) has convened 39 public meetings to review data and consider recommendations related to the use of COVID-19 vaccines (1). [...]

Published
2024

8. Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices--United States, 2023

Author

Kidd, Sarah, Clark, Thomas, Routh, Janell, Cineas, Sybil, Bahta, Lynn, and Brooks, Oliver

Subjects
Vaccination -- Usage, Neomycin -- Usage, Paralysis -- Usage, Adults -- Usage, Epidemiology -- Usage, Poliomyelitis -- Usage, Vaccines -- Usage, Health
Abstract

Introduction Poliovirus infection can cause poliomyelitis and permanent paralysis. The incidence of paralytic polio in the United States decreased rapidly after introduction of the Salk inactivated poliovirus vaccine (IPV) in [...]

Published
2023

9. The hydrogen ductilisation process (HyDP) for NdFeB alloys

Author

Brooks, Oliver Peter

Subjects
669, TN Mining engineering. Metallurgy, TP Chemical technology
Abstract

The work in this thesis aims to investigate the ductility of s-HD (solid hydrogenation disproportionation) processed book mould cast NdFeB material in order to develop a novel processing route for producing fully dense magnetic material with a high energy product. A major drawback of NdFeB–based alloys is that they are extremely brittle. Therefore, to produce a fully dense magnet these alloys must be broken down into a powder and hot pressed or sintered followed by cutting and grinding to the desired shape and precise dimensions. This process is time consuming, energy intensive and produces a significant amount of waste which is not readily recyclable. This thesis reports a potentially new application of hydrogen as a promising high temperature processing tool in which the normally brittle Nd\(_2\)Fe\(_1\)\(_4\)B based intermetallic absorbs and reacts with hydrogen, converting it into a ductile, disproportionated condition, which can be subsequently compressed at room temperature. It can then be restored to its original state by removal of the hydrogen under partial vacuum at elevated temperatures. By maintaining a solid form throughout, almost zero waste material is produced and the deformed material exhibits a high coercivity and a useful degree of anisotropy.

Published
2018

10. Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices -United States, 2024–2025.

Author

Panagiotakopoulos, Lakshmi, Moulia, Danielle L., Godfrey, Monica, Link-Gelles, Ruth, Roper, Lauren, Havers, Fiona P., Taylor, Christopher A., Stokley, Shannon, Talbot, H. Keipp, Schechter, Robert, Brooks, Oliver, Daley, Matthew F., Fleming-Dutra, Katherine E., and Wallace, Megan

Subjects
COVID-19 vaccines, VACCINE effectiveness
Abstract

COVID-19 vaccination provides additional protection against severe COVID-19–associated illness and death. Since September 2023, 2023–2024 Formula monovalent XBB.1-strain COVID-19 vaccines have been recommended for use in the United States for all persons aged ≥6 months. However, SARS-CoV-2 continues to evolve, and since winter 2023–2024, Omicron JN.1 lineage strains of SARS-CoV-2, including the JN.1 strain and the KP.2 strain, have been widely circulating in the United States. Further, COVID-19 vaccine effectiveness is known to wane. On June 27, 2024, the Advisory Committee on Immunization Practices (ACIP) recommended 2024–2025 COVID-19 vaccination with a Food and Drug Administration (FDA)–approved or authorized vaccine for all persons aged ≥6 months. On August 22, 2024, FDA approved the 2024–2025 COVID-19 vaccines by Moderna and Pfizer-BioNTech (based on the KP.2 strain) for use in persons aged ≥12 years and authorized these vaccines for use in children aged 6 months–11 years under Emergency Use Authorization (EUA). On August 30, 2024, FDA authorized 2024–2025 COVID-19 vaccine by Novavax (based on the JN.1 strain) for use in persons aged ≥12 years under EUA. ACIP will continue to evaluate new evidence as it becomes available and will update recommendations as needed. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

12. Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024

Author

Panagiotakopoulos, Lakshmi, primary, Godfrey, Monica, additional, Moulia, Danielle L., additional, Link-Gelles, Ruth, additional, Taylor, Christopher A., additional, Chatham-Stephens, Kevin, additional, Brooks, Oliver, additional, Daley, Matthew F., additional, Fleming-Dutra, Katherine E., additional, and Wallace, Megan, additional

Published
2024
Full Text
View/download PDF

13. Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged [greater than or equal to] 6 Months: Recommendations of the Advisory Committee on Immunization Practices--United States, September 2023

Author

Regan, Joanna J., Moulia, Danielle L., Link-Gelles, Ruth, Godfrey, Monica, Mak, Josephine, Najdowski, Morgan, Rosenblum, Hannah G., Shah, Melisa M., Twentyman, Evelyn, Meyer, Sarah, Peacock, Georgina, Thornburg, Natalie, Havers, Fiona P., Saydah, Sharon, Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Mahon, Barbara E., Daley, Matthew F., Fleming-Dutra, Katherine E., and Wallace, Megan

Subjects
United States. Food and Drug Administration, Pfizer Inc., Vaccination -- Usage, RNA -- Usage, Drug approval -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Health
Abstract

On October 10, 2023, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Introduction By the end of 2022, COVID-19 vaccines had prevented 18.5 million [...]

Published
2023

14. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices--United States, 2023

Author

Fleming-Dutra, Katherine E., Jones, Jefferson M., Roper, Lauren E., Prill, Mila M., Ortega-Sanchez, Ismael R., Moulia, Danielle L., Wallace, Megan, Godfrey, Monica, Broder, Karen R., Tepper, Naomi K., Brooks, Oliver, Sanchez, Pablo J., Kotton, Camille N., Mahon, Barbara E., Long, Sarah S., and McMorrow, Meredith L.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., AstraZeneca PLC, Sanofi S.A., Vaccination -- Usage, Diseases -- Prevention -- United States -- France -- United Kingdom, Infants -- Usage, Drug approval -- Usage, Epidemiology -- Usage, Vaccines -- Usage, Pregnant women -- Usage, Pharmaceutical industry -- Usage, Health, Abrysvo (Vaccine) -- Usage
Abstract

On October 6, 2023, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Introduction In August 2023, the Food and Drug Administration (FDA) approved RSVpreF [...]

Published
2023

15. "I mainly come for the pies" : an ethnographic study of contemporary football culture

Author

Brooks, Oliver

Subjects
796.332
Abstract

This thesis endeavours to develop a more nuanced understanding of contemporary football culture. As such my research adopts a consumer-oriented cultural studies approach to analyse the ways in which modern ‘consumer’ fans negotiate their position within football culture and the power operating upon them as they do so. Drawing on data from unique ethnographic research I argue that modern fans engage in processes of complex discursive negotiation, constructing their identities at the juncture of the hegemonic discourses that surround football culture: capitalism and tradition, but also their individual understanding of how they are expected to enact fandom. I argue that modern fans are able to negotiate the discourses of capitalism and tradition operating upon them to enact their own power and identity within football culture. As such, this thesis seeks to advance debates about collective identity formation and the scope of representation within contemporary football culture. In doing so, my research contributes to football scholarship’s long tradition of making perceptive social commentaries, drawing on football culture to contribute to wider debates concerning capitalism and collective identity formation.

Published
2014

16. Racism in pediatric health and How to talk to children about racism

Author

Walton, Jennifer, Freeman, Brandi Kaye, Tyler-Hill, Yasmin, Brooks, Oliver, and Smitherman, Lynn

Subjects
Pediatrics -- Rites, ceremonies and celebrations -- Social aspects, Racism -- Social aspects -- Rites, ceremonies and celebrations, Children -- Health aspects, Native Americans -- Rites, ceremonies and celebrations -- Social aspects, African Americans -- Social aspects -- Rites, ceremonies and celebrations, Health, Health care industry
Abstract

Since the inception of the United States, social, economic, political, and scientific institutions have been built on a foundation emphasizing the inferiority of individuals related to phenotypic differences. (1) This [...]

Published
2021

17. Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023

Author

Regan, Joanna J., primary, Moulia, Danielle L., additional, Link-Gelles, Ruth, additional, Godfrey, Monica, additional, Mak, Josephine, additional, Najdowski, Morgan, additional, Rosenblum, Hannah G., additional, Shah, Melisa M., additional, Twentyman, Evelyn, additional, Meyer, Sarah, additional, Peacock, Georgina, additional, Thornburg, Natalie, additional, Havers, Fiona P., additional, Saydah, Sharon, additional, Brooks, Oliver, additional, Talbot, H. Keipp, additional, Lee, Grace M., additional, Bell, Beth P., additional, Mahon, Barbara E., additional, Daley, Matthew F., additional, Fleming-Dutra, Katherine E., additional, and Wallace, Megan, additional

Published
2023
Full Text
View/download PDF

19. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

Author

Jones, Jefferson M., primary, Fleming-Dutra, Katherine E., additional, Prill, Mila M., additional, Roper, Lauren E., additional, Brooks, Oliver, additional, Sánchez, Pablo J., additional, Kotton, Camille N., additional, Mahon, Barbara E., additional, Meyer, Sarah, additional, Long, Sarah S., additional, and McMorrow, Meredith L., additional

Published
2023
Full Text
View/download PDF

20. Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines--United States, October 2022

Author

Rosenblum, Hannah G., Wallace, Megan, Godfrey, Monica, Roper, Lauren E., Hall, Elisha, Fleming-Dutra, Katherine E., Link-Gelles, Ruth, Pilishvili, Tamara, Williams, Jennifer, Moulia, Danielle L., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Daley, Matthew F., Meyer, Sarah, Oliver, Sara E., and Twentyman, Evelyn

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., Vaccination -- Usage, RNA -- Usage, Vaccines -- Usage, Health
Abstract

Four COVID-19 vaccines are currently approved for primary series vaccination in the United States under a Biologics License Application or authorized under an emergency use authorization (EUA) by the Food [...]

Published
2022

29. Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged [greater than or equal to] 18 years--United States, July 2022

Author

Twentyman, Evelyn, Wallace, Megan, Roper, Lauren E., Anderson, Tara C., Rubis, Amy B., Fleming-Dutra, Katherine E., Hall, Elisha, Hsu, Joy, Rosenblum, Hannah G., Godfrey, Monica, Archer, W. Roodly, Moulia, Danielle L., Daniel, Laura, Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Daley, Matthew, Meyer, Sarah, and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Vaccines -- Usage, Health
Abstract

The NVX-CoV2373 (Novavax) COVID-19 vaccine is a recombinant spike (rS) protein nanoparticle vaccine with Matrix-M adjuvant to protect against infection with SARS-CoV-2, the virus that causes COVID-19. On July 13, [...]

Published
2022

30. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years--United States, June 2022

Author

Fleming-Dutra, Katherine E., Wallace, Megan, Moulia, Danielle L., Twentyman, Evelyn, Roper, Lauren E., Hall, Elisha, Link-Gelles, Ruth, Godfrey, Monica, Woodworth, Kate R., Anderson, Tara C., Rubis, Amy B., Shanley, Edwin, III, Jones, Jefferson M., Morgan, Rebecca L., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Daley, Matthew, Meyer, Sarah, and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., Children's furniture -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Health
Abstract

On June 28, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). On June 17, 2022, the Food and Drug Administration (FDA) issued Emergency [...]

Published
2022

31. The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged [greater than or equal to]18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines--United States, February 2022

Author

Wallace, Megan, Moulia, Danielle, Blain, Amy E., Ricketts, Erin K., Minhaj, Faisal S., Link-Gelles, Ruth, Curran, Kathryn G., Hadler, Stephen C., Asif, Amimah, Godfrey, Monica, Hall, Elisha, Fiore, Anthony, Meyer, Sarah, Su, John R., Weintraub, Eric, Oster, Matthew E., Shimabukuro, Tom T., Campos- Outcalt, Doug, Morgan, Rebecca L., Bell, Beth P., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Daley, Matthew F., and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., Messenger RNA -- Usage -- Health aspects, Adults -- Health aspects -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Health aspects -- Usage, Health
Abstract

The mRNA-1273 (Moderna) COVID-19 vaccine is a lipid nanoparticle-encapsulated, nucleoside-modified mRNA vaccine encoding the stabilized prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. During December 2020, the vaccine [...]

Published
2022

32. Perceptions of strategic decision‐making by crisis management teams during exercising: Establishing key dimensions.

Author

Curnin, Steven, Brooks, Benjamin, Owen, Christine, and Brooks, Oliver

Subjects
CRISIS management, DECISION making, PRINCIPAL components analysis, PSYCHOLOGICAL safety, GOVERNMENT agencies
Abstract

To survive and thrive in a crisis requires crisis management teams (CMTs) to make sound strategic decisions. This paper examines the perceptions of CMTs from a group of nonresponse organisations to identify dimensions of the strategic decision‐making process during a crisis management exercise. The paper draws on data collected during a series of exercises with seven Australian government agencies and businesses. Using principal component analysis, this paper outlines four dimensions that are perceived to support strategic decision‐making in this context—psychological safety, critical thinking, managing expectations and adaptive capability. Embedding these dimensions within key systems and processes can provide CMTs with the structure they need to effectively respond to a crisis and enhance organisational resilience. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

34. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices--United States, December 2021

Author

Oliver, Sara E., Wallace, Megan, See, Isaac, Mbaeyi, Sarah, Godfrey, Monica, Hadler, Stephen C., Jatlaoui, Tara C., Twentyman, Evelyn, Hughes, Michelle M., Rao, Agam K., Flore, Anthony, Su, John R., Broder, Karen R., Shimabukuro, Tom, Lale, Allison, Shay, David K., Markowitz, Lauri E., Wharton, Melinda, Bell, Beth P., Brooks, Oliver, McNally, Veronica, Lee, Grace M., Talbot, H. Keipp, and Daley, Matthew F.

Subjects
United States. Food and Drug Administration, Johnson & Johnson, Vaccination -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Health
Abstract

On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the adenovirus-vectored COVID-19 vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, Johnson & [...]

Published
2022

35. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years--United States, November 2021

Author

Woodworth, Kate R., Moulia, Danielle, Collins, Jennifer P., Hadler, Stephen C., Jones, Jefferson M., Reddy, Sujan C., Chamberland, Mary, Campos-Outcalt, Doug, Morgan, Rebecca L., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Daley, Matthew F., Mbaeyi, Sarah, Dooling, Kathleen, and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., Drug approval -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Health
Abstract

On November 5, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). The Pfizer-BioNTech COVID-19 (BNT162b2) vaccine is a lipid nanoparticle--formulated, nucleoside-modified mRNA vaccine [...]

Published
2021

36. The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines--United States, 2021

Author

Mbaeyi, Sarah, Oliver, Sara E., Collins, Jennifer P., Godfrey, Monica, Goswami, Neela D., Hadler, Stephen C., Jones, Jefferson, Moline, Heidi, Moulia, Danielle, Reddy, Sujan, Schmit, Kristine, Wallace, Megan, Chamberland, Mary, Campos-Outcalt, Doug, Morgan, Rebecca L., Bell, Beth P., Brooks, Oliver, Kotton, Camille, Talbot, H. Keipp, Lee, Grace, Daley, Matthew F., and Dooling, Kathleen

Subjects
United States. Food and Drug Administration, Pfizer Inc., Vaccination, RNA, Vaccines, Pharmaceutical industry, Health
Abstract

On October 29, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Three COVID-19 vaccines are currently approved under a Biologics License Application (BLA) [...]

Published
2021

37. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged [greater than or equal to] 16 Years: Recommendations of the Advisory Committee on Immunization Practices--United States, September 2021

Author

Dooling, Kathleen, Gargano, Julia W., Moulia, Danielle, Wallace, Megan, Rosenblum, Hannah G., Blain, Amy E., Hadler, Stephen C., Plumb, Ian D., Moline, Heidi, Gerstein, Jack, Collins, Jennifer P., Godfrey, Monica, Campos-Outcalt, Doug, Morgan, Rebecca L., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Daley, Matthew F., and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, Pfizer Inc., Vaccination -- Health aspects -- Usage, Medical colleges -- Health aspects -- Usage, Vaccines -- Usage, Health
Abstract

On September 21, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). The Pfizer-BioNTech COVID-19 vaccine (BNT162b2) is a lipid nanoparticle-formulated, nucleoside mRNA vaccine [...]

Published
2021

38. Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022

Author

Twentyman, Evelyn, primary, Wallace, Megan, additional, Roper, Lauren E., additional, Anderson, Tara C., additional, Rubis, Amy B., additional, Fleming-Dutra, Katherine E., additional, Hall, Elisha, additional, Hsu, Joy, additional, Rosenblum, Hannah G., additional, Godfrey, Monica, additional, Archer, W. Roodly, additional, Moulia, Danielle L., additional, Daniel, Laura, additional, Brooks, Oliver, additional, Talbot, H. Keipp, additional, Lee, Grace M., additional, Bell, Beth P., additional, Daley, Matthew, additional, Meyer, Sarah, additional, and Oliver, Sara E., additional

Published
2022
Full Text
View/download PDF

39. Recommended Adult Immunization Schedule, United States, 2023.

Author

Murthy, Neil, Wodi, A. Patricia, Cineas, Sybil, Ault, Kevin A., Lee, Grace M., Wharton, Melinda, Bahta, Lynn, Bell, Beth P., Brooks, Oliver, Chen, Wilbur H., Daley, Matthew F., Kotton, Camille Nelson, Loehr, Jamie, Long, Sarah S., McNally, Veronica V., Poehling, Katherine A., Sánchez, Pablo J., Shah, Nirav D., Talbot, Helen Keipp, and McNally, Veronica

Subjects
IMMUNIZATION, ADULTS, SCHEDULING, VACCINATION
Abstract

This article provides immunization recommendations from the Advisory Committee on Immunization Practices (ACIP) for adults aged 19 years or older. The purpose of the immunization schedule is to consolidate and summarize updates to ACIP recommendations on vaccination of adults and to assist providers in implementing current ACIP recommendations. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

40. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021

Author

Dooling, Kathleen, primary, Gargano, Julia W., additional, Moulia, Danielle, additional, Wallace, Megan, additional, Rosenblum, Hannah G., additional, Blain, Amy E., additional, Hadler, Stephen C., additional, Plumb, Ian D., additional, Moline, Heidi, additional, Gerstein, Jack, additional, Collins, Jennifer P., additional, Godfrey, Monica, additional, Campos-Outcalt, Doug, additional, Morgan, Rebecca L., additional, Brooks, Oliver, additional, Talbot, H. Keipp, additional, Lee, Grace M., additional, Daley, Matthew F., additional, and Oliver, Sara E., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results